Disease Drug Development Treatment White Paper 
Conversations in Drug Development Trends
MARCH 20, 2024
In the increasingly advancing world of medicine, personalized care is a key factor that can progress your drug development efforts. One way to ensure customized disease management is to utilize pharmacogenomics (PGx) in your clinical trial.
PPD
MARCH 21, 2024
When participating in clinical trials, pediatric populations require distinct considerations for their safety and well-being — which can present unique challenges for drug developers. A number of strategies can be adopted to put the needs of the child at the center of the study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Conversations in Drug Development Trends
NOVEMBER 21, 2023
Since the advent of modern medicine, the scientific community has developed more than 3,000 drugs for thousands of diseases. Despite significant progress, there are more than 6,500 rare diseases without a single approved treatment. There are so many patients suffering from diseases that have no treatments.
Conversations in Drug Development Trends
AUGUST 14, 2024
By: Simran Padam, Medical Director, Medical Affairs Personalized treatment approaches have emerged as pivotal in improving outcomes for hematological cancers. Heterogeneity in Hematological Cancers Due to their disease heterogeneity, hematological cancers are well-suited for personalized approaches.
The Pharma Data
DECEMBER 28, 2020
Scopus is a biopharmaceutical company whose lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. Dr. Russell has managed all aspects of the drug development and regulatory approval processes for oncology and non-oncology drug candidates. David Weild IV.
Conversations in Drug Development Trends
MARCH 12, 2024
From their use in risk and safety assessments to patient screening and treatment efficacy, biomarkers offer minimally invasive, objective data. For a more in-depth look at biomarkers, check out our white paper. Deviations from established baseline values provide insights into treatment response in certain cancer indications.
Conversations in Drug Development Trends
MARCH 1, 2024
Master protocols allow a trial to perform multiple tests on diverse patient populations or diseases under a unified design. Umbrella Studies Umbrella studies evaluate multiple investigational products (IPs) within a single disease. But how do they work, and when are they appropriate? What Are Master Protocols? Contact us.
Expert insights. Personalized for you.
52 
Let's personalize your content